Verapamil effects on left ventricular hypertrophy induced by isoproterenol;Efeito do verapamil na hipertrofia ventricular esquerda induzida pelo isoproterenol

Arquivos Brasileiros de Cardiologia

Volumn 67, Issue 2, 1996, Pages 81-85

  Bombig, Maria Teresa Nogueira ^a  

^a NONE   (Brazil)

Author keywords

isoproterenol; myocardial protection; ventricular hypertrophy; verapamil

Indexed keywords

COLLAGEN; ISOPRENALINE; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART LEFT VENTRICLE HYPERTROPHY; HEART PROTECTION; HEMODYNAMICS; MALE; NONHUMAN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029842354     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Kannel WB, Gordon TO - Left ventricular hypertrophy by ECG prevalence, incidence and mortality in the framinghan study. Ann Intern Med 1969; 71: 89-105.
2. Kannel WB, Levy D,Cupples LA - Left ventricular hypertrophy and risk of cardiac failure: insights from the Framingham study. J Cardiovasc Pharmacol 1987; 10: S135-S40,
3. Messerli FH, Ventura HO - Cardiovascular pathophysiology of essential hypertension: a clue to therapy. Drugs 1985; 30(suppl I): 25-34.
4. Mclenachan JM, Henderson E, Morris KL, Dergie HJ - Ventricular arrhytmias in hypertensive left ventricular hypertrophy. N Engl J Med 1987; 317: 787-92.